Opportunity Information: Apply for CDC RFA GH21 2107
This funding opportunity is a CDC cooperative agreement focused on strengthening the Bangkok Metropolitan Administration (BMA) so it can better detect, prevent, respond to, monitor, and reduce the impacts of public health threats across Bangkok and surrounding urban areas. The core idea is technical collaboration: CDC is looking to work through a partner to help BMA improve how it assesses health needs, standardizes high-quality services, and builds the skills of the workforce that delivers and oversees those services. The program is designed to complement BMA efforts already underway with national and international partners, and it leans heavily on the idea that stronger systems, better data use, and consistent quality standards make public health responses faster and more effective.
The work described is organized around three main tracks. First is a thorough assessment of current health behaviors and the existing health care services and systems in Bangkok, essentially creating a clear picture of what is happening on the ground and where the major gaps are. Second is the design, development, and rollout of standardized procedures and practices so that BMA health facilities and laboratories can deliver more consistent, high-quality services. Third is capacity building and mentorship for BMA personnel, including health care workers, lab staff, strategic information (SI) specialists, and program managers. That mentorship component is not just training for its own sake; it is aimed at helping staff implement the new procedures, measure whether they are working, and continuously improve them over time.
The opportunity is grounded in a long history of collaboration between CDC and BMA, described as more than 20 years of joint work to strengthen Bangkok's public health infrastructure. Past efforts are credited with progress in controlling HIV and other infectious diseases, improving access to diagnosis, care, and treatment for both communicable and non-communicable diseases, and strengthening surveillance and evidence-based decision-making, including how public health financing is guided in the Bangkok area. This grant positions itself as the next step in that evolution, responding to current and emerging threats while reinforcing the systems that support routine public health services.
A major driver behind the program is Thailand's changing risk landscape. Over recent decades, Thailand has experienced significant social, economic, and demographic shifts, including an aging population and increased exposure to non-communicable disease risk factors such as unhealthy diets, low physical activity, tobacco use, and harmful alcohol use. At the same time, infectious diseases and emerging infections remain major concerns in Thailand and the broader Mekong region, with global implications due to travel and cross-border movement. Another central concern is antimicrobial resistance (AMR), which is described as rapidly growing, fueled in part by rising gram-negative resistance and antibiotic overuse. Thailand has elevated AMR as a national priority and developed a National Strategic Plan to prevent and control it, and this cooperative agreement sits within that broader national urgency.
HIV is highlighted as a particularly important focus area in Bangkok. The notice cites an estimated 470,000 people living with HIV in Thailand in 2019, with about 78,866 in Bangkok. While national HIV incidence has declined, prevalence and incidence remain high among key populations in large urban centers, especially men who have sex with men (MSM), transgender women, and sex workers. The document points to progress among MSM in Bangkok, with HIV prevalence declining from 20 percent in 2014 to 10 percent in 2018, but it still emphasizes ongoing transmission. Using the Asian Epidemic Model, it estimates 1,063 new HIV infections in Bangkok in 2020, out of 4,855 nationwide, underscoring Bangkok's outsized role in the national epidemic.
One of the biggest barriers described is health system fragmentation. Bangkok has multiple public entities and private providers, and the current setup does not reliably deliver an integrated continuum that links prevention, HIV testing and counseling (HTC), clinical care, antiretroviral treatment, co-infection management (including tuberculosis, sexually transmitted infections, and hepatitis), and supportive services that meet the needs of people living with HIV and priority populations, including MSM, transgender women and their partners, and people who inject drugs. The grant emphasizes the need to implement standards for same-day, high-quality, patient-friendly HTC, including modern approaches such as online-to-offline testing pathways, index testing, and self-testing. It also stresses immediate linkage to care, same-day or rapid ART initiation, and stronger practices to retain clients in treatment and maintain continuity of care. Alongside service improvements, it calls for building the capacity of health care workers and laboratory staff to implement these approaches, monitor performance, and continuously improve quality.
Beyond individual services, the notice also calls for more systematic public health responses in areas where recent infections are being identified, implying more targeted, data-driven outbreak control and prevention activities in priority geographic areas or networks. The broader framing goes beyond HIV: the cooperative agreement is also positioned to improve BMA capacity to respond to influenza and other public health challenges, reinforcing preparedness and response capabilities across multiple threats. In doing so, the program highlights the importance of multi-sector and regional collaboration, aiming for sustainable improvements that matter for Thailand and align with CDC global health strategies and U.S. public health priorities.
Administratively, this is a discretionary CDC funding opportunity under a cooperative agreement mechanism, meaning CDC expects substantial involvement and partnership during implementation rather than a hands-off grant. The opportunity number is CDC-RFA-GH21-2107, housed within HHS/CDC (CGH). It lists CFDA numbers 93.067 and 93.318, anticipates a single award, and sets an award ceiling of $1,000,000. The original application deadline listed is July 6, 2021, with electronic submissions due by 11:59 pm Eastern Time. Eligibility is labeled broadly as "Others" with further clarification referenced in an additional eligibility field, indicating it may be aimed at specific organizational types capable of delivering technical assistance, training, quality improvement, and systems strengthening in close coordination with BMA and CDC.Apply for CDC RFA GH21 2107
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Technical Collaboration to Strengthen Bangkok Metropolitan Administration Capacity to Detect, Prevent, Respond, Monitor, and Mitigate The Effects of Public Health Threats In The Kingdom of Thailand." and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067, 93.318.
- This funding opportunity was created on May 05, 2021.
- Applicants must submit their applications by Jul 06, 2021 Electronically submitted applications must be submitted no later than 1159 pm ET on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
1. What is this funding opportunity about?
This CDC cooperative agreement supports technical collaboration to strengthen the Bangkok Metropolitan Administration (BMA) so it can better detect, prevent, respond to, monitor, and reduce the impacts of public health threats across Bangkok and surrounding urban areas. The emphasis is on improving systems, data use, and consistent quality standards so public health responses are faster and more effective.
2. Who is the funder and what type of award is this?
The funder is the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), within the Center for Global Health (CGH). The mechanism is a cooperative agreement, which means CDC expects substantial involvement and partnership during implementation rather than a hands-off grant.
3. What is the opportunity number?
The opportunity number is CDC-RFA-GH21-2107.
4. What are the CFDA numbers associated with this opportunity?
The notice lists CFDA numbers 93.067 and 93.318.
5. How many awards does CDC anticipate making?
The opportunity anticipates a single award.
6. What is the maximum funding amount available?
The award ceiling is $1,000,000.
7. When was the application deadline?
The original application deadline listed is July 6, 2021, with electronic submissions due by 11:59 pm Eastern Time.
8. What geographic area is the program focused on?
The focus is Bangkok and surrounding urban areas, with the work centered on strengthening the Bangkok Metropolitan Administration (BMA) and its health-related systems and services.
9. What is the overall approach CDC is seeking through this cooperative agreement?
The core approach is technical collaboration through a partner to help BMA improve how it assesses health needs, standardizes high-quality services, and builds workforce skills. The program is designed to complement BMA efforts already underway with national and international partners.
10. What are the main tracks of work described in the opportunity?
The work is organized around three main tracks:
- A thorough assessment of current health behaviors and the existing health care services and systems in Bangkok to identify major gaps.
- Design, development, and rollout of standardized procedures and practices so BMA health facilities and laboratories can deliver more consistent, high-quality services.
- Capacity building and mentorship for BMA personnel (health care workers, lab staff, strategic information specialists, and program managers) focused on implementing procedures, measuring performance, and continuously improving quality.
11. What does "capacity building and mentorship" mean in this program?
It goes beyond one-time training. The mentorship is intended to help BMA staff implement new procedures, monitor whether they are working, and use results for continuous quality improvement over time.
12. Why is CDC investing in this work now?
The opportunity is framed as a response to Thailand's changing risk landscape, including demographic shifts (such as an aging population), growing non-communicable disease (NCD) risk factors (unhealthy diets, low physical activity, tobacco use, harmful alcohol use), ongoing concerns about infectious diseases and emerging infections, and rapidly growing antimicrobial resistance (AMR).
13. How does antimicrobial resistance (AMR) relate to this cooperative agreement?
AMR is described as a rapidly growing concern, driven in part by rising gram-negative resistance and antibiotic overuse. Thailand has elevated AMR as a national priority and developed a National Strategic Plan to prevent and control it, and this cooperative agreement is positioned within that broader national urgency.
14. Why is HIV a highlighted focus area for Bangkok?
The notice emphasizes Bangkok's outsized role in Thailand's HIV epidemic. It cites estimates of 470,000 people living with HIV in Thailand in 2019, including about 78,866 in Bangkok. While national HIV incidence has declined, prevalence and incidence remain high among key populations in large urban centers.
15. Which populations are specifically mentioned as key HIV-affected groups in Bangkok?
The document highlights men who have sex with men (MSM), transgender women, and sex workers as key populations with ongoing high HIV burden in large urban settings. It also mentions priority populations including MSM, transgender women and their partners, and people who inject drugs in the context of service needs.
16. What HIV trend among MSM in Bangkok is mentioned?
The notice cites progress among MSM in Bangkok, with HIV prevalence declining from 20 percent in 2014 to 10 percent in 2018, while still emphasizing ongoing transmission.
17. What does the opportunity say about new HIV infections in Bangkok?
Using the Asian Epidemic Model, the notice estimates 1,063 new HIV infections in Bangkok in 2020, out of 4,855 nationwide.
18. What major system barrier does the notice identify?
The notice describes health system fragmentation as a major barrier. With multiple public entities and private providers, the current setup does not reliably deliver an integrated continuum linking prevention, HIV testing and counseling, clinical care, antiretroviral treatment, co-infection management, and supportive services.
19. What parts of the HIV service continuum are specifically mentioned?
The notice references an integrated continuum that links:
- Prevention
- HIV testing and counseling (HTC)
- Clinical care
- Antiretroviral treatment (ART)
- Co-infection management (including tuberculosis, sexually transmitted infections, and hepatitis)
- Supportive services
20. What improvements to HIV testing and counseling (HTC) are emphasized?
The grant emphasizes standards for same-day, high-quality, patient-friendly HTC, including modern approaches such as online-to-offline testing pathways, index testing, and self-testing.
21. What does the notice say about linkage to care and treatment initiation?
It stresses immediate linkage to care and same-day or rapid antiretroviral therapy (ART) initiation, along with stronger practices to retain clients in treatment and maintain continuity of care.
22. How does laboratory capacity fit into the program?
Laboratories are included in the standardization and workforce development tracks. The opportunity calls for standardized procedures and practices for laboratories and for building the capacity of laboratory staff to implement approaches, monitor performance, and continuously improve quality.
23. What is meant by "standardized procedures and practices" in this context?
It refers to designing, developing, and rolling out consistent procedures so that BMA health facilities and laboratories deliver more uniform, high-quality services, supported by measurement and ongoing quality improvement.
24. What does the opportunity say about data and strategic information (SI)?
Strategic information (SI) specialists are explicitly included in the capacity building and mentorship track. The overall framing emphasizes stronger systems and better data use to guide decision-making, monitor performance, and improve services over time.
25. Does this program only address HIV?
No. While HIV is a major focus area, the cooperative agreement is also positioned to improve BMA capacity to respond to influenza and other public health challenges, reinforcing preparedness and response capabilities across multiple threats.
26. What is the role of assessments in this program?
The first main track is a thorough assessment of current health behaviors and existing health care services and systems in Bangkok, intended to create a clear picture of conditions on the ground and identify major gaps that the program should address.
27. What does the notice indicate about targeted responses where recent infections are identified?
The notice calls for more systematic public health responses in areas where recent infections are being identified, implying targeted, data-driven outbreak control and prevention activities in priority geographic areas or networks.
28. How does this opportunity relate to past CDC-BMA collaboration?
The opportunity is grounded in more than 20 years of CDC-BMA collaboration to strengthen Bangkok's public health infrastructure, with past efforts credited with progress in controlling HIV and other infectious diseases, improving access to diagnosis, care, and treatment for communicable and non-communicable diseases, and strengthening surveillance and evidence-based decision-making.
29. How is this program meant to fit alongside other partners already working with BMA?
It is designed to complement BMA efforts already underway with national and international partners, rather than replace them, by strengthening systems, quality standards, workforce capacity, and data use.
30. What does "multi-sector and regional collaboration" mean in this notice?
The program highlights the importance of collaboration across sectors and at the regional level to achieve sustainable improvements that matter for Thailand and align with CDC global health strategies and U.S. public health priorities.
31. Who is eligible to apply?
Eligibility is labeled broadly as "Others," with additional clarification referenced in an additional eligibility field. Based on the description, the applicant is expected to be an organizational type capable of delivering technical assistance, training, quality improvement, and systems strengthening in close coordination with BMA and CDC.
32. What kind of partner is CDC looking for?
CDC is looking to work through a partner that can support BMA through technical collaboration, including conducting assessments, developing and implementing standardized procedures for facilities and laboratories, and providing mentorship and capacity building for BMA personnel across clinical, laboratory, strategic information, and program management roles.
Browse more opportunities from the same category: Health
Next opportunity: FY21 Choice Neighborhoods Planning Grants NOFO
Previous opportunity: Fiscal Year (FY) 2021 Multi-State and National Earthquake Assistance
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH21 2107
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH21 2107) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research Program Award (R35 Clinical Trial Optional) Apply for RFA NS 21 020 Funding Number: RFA NS 21 020 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Regional Pediatric Pandemic Network Apply for HRSA 21 104 Funding Number: HRSA 21 104 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $9,700,000 |
| Enhancing Water, Sanitation and Hygiene (WASH) Activity Apply for 72064121RFA00003 Funding Number: 72064121RFA00003 Agency: Agency for International Development, Ghana USAID-Accra Category: Health Funding Amount: $39,000,000 |
| Closing the Gap with Social Determinants of Health Accelerator Plans Apply for CDC RFA DP21 2111 Funding Number: CDC RFA DP21 2111 Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $125,000 |
| Children’s Hospitals Graduate Medical Education (CHGME) Payment Program Apply for HRSA 22 051 Funding Number: HRSA 22 051 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| CDC's Collaboration with Academia to Strengthen Public Health Workforce Capacity Apply for CDC RFA OE17 17010502SUPP21 Funding Number: CDC RFA OE17 17010502SUPP21 Agency: Department of Health and Human Services, Centers for Disease Control - CSELS Category: Health Funding Amount: $2,000,000 |
| Strengthening detection, prevention and response to infectious disease threats in Kazakhstan Apply for CDC RFA GH21 2167 Funding Number: CDC RFA GH21 2167 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Rural Northern Border Region Planning Program Apply for HRSA 21 106 Funding Number: HRSA 21 106 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $190,000 |
| Strengthening detection, prevention and response to infectious disease threats in Uzbekistan Apply for CDC RFA GH21 2169 Funding Number: CDC RFA GH21 2169 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Projects of National Significance: Empowering Youth with Intellectual and Developmental Disabilities to Manage Their Healthcare Transitions Apply for HHS 2021 ACL AOD DNCE 0100 Funding Number: HHS 2021 ACL AOD DNCE 0100 Agency: Department of Health and Human Services, Administration for Community Living Category: Health Funding Amount: $485,000 |
| Family-Centered Approaches to Improving Type 2 Diabetes Control and Prevention Apply for MP CPI 21 001 Funding Number: MP CPI 21 001 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $500,000 |
| Community Led Monitoring Activity in the Kyrgyz Republic Apply for 72011521RFA00008 Funding Number: 72011521RFA00008 Agency: Agency for International Development, Kazakhstan USAID-Almaty Category: Health Funding Amount: $160,000 |
| National HIV Behavioral Surveillance (NHBS) Apply for CDC RFA PS22 2201 Funding Number: CDC RFA PS22 2201 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 22 002 Funding Number: HRSA 22 002 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Area Health Education Centers (AHEC) - Simulation Education Training (SET) Competitive Supplement Apply for HRSA 21 103 Funding Number: HRSA 21 103 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Tribal Public Health Capacity-Building and Quality Improvement Umbrella Cooperative Agreement Apply for CDC RFA OT18 18030401SUPP21 Funding Number: CDC RFA OT18 18030401SUPP21 Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS Category: Health Funding Amount: Case Dependent |
| Shoulder to Shoulder: Accompanying Ministries of Health in Central America in Strengthening Local and Global Health Security Apply for CDC RFA GH21 2164 Funding Number: CDC RFA GH21 2164 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Optimizing Virtual Care (OVC) Apply for HRSA 22 097 Funding Number: HRSA 22 097 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $2,000,000 |
| Capacity Building and Strengthening of Hospital Infection Control to detect, prevent and respond to antimicrobial resistance in India Apply for CDC RFA GH21 2173 Funding Number: CDC RFA GH21 2173 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Discovery & Exploration of Emerging Pathogens – Viral Zoonoses (DEEP VZN) Apply for 7200AA21RFA00005 Funding Number: 7200AA21RFA00005 Agency: Agency for International Development Category: Health Funding Amount: $125,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH21 2107", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.